MCAS diagnosis in the UK: the NHS pathway, private routes and what to ask for

What MCAS is

Mast Cell Activation Syndrome (MCAS) is a condition in which mast cells, the immune cells responsible for allergic and anaphylactic reactions, release histamine, tryptase, prostaglandins and other mediators inappropriately, in response to triggers that wouldn't normally provoke a reaction. The result is recurrent, multi-system symptoms: flushing, urticaria, abdominal pain and diarrhoea, brain fog, tachycardia, presyncope, and in severe cases anaphylaxis.

It sits in the same family as systemic mastocytosis (where there are too many mast cells) and idiopathic anaphylaxis. Unlike mastocytosis, in MCAS the number of mast cells is usually normal, the problem is that they are easily and inappropriately activated.

The diagnostic criteria

The international consensus criteria (Valent et al., 2012, updated 2019) require all three of:

• Typical clinical features, recurrent, episodic symptoms affecting at least two organ systems consistent with mast cell mediator release.
• Objective evidence of mast cell mediator release, most commonly a rise in serum tryptase of at least 20% above baseline plus 2 ng/mL, measured within 1 to 4 hours of a symptomatic episode.
• Response to mast-cell-directed therapy, symptoms improve with H1 and H2 antihistamines, mast cell stabilisers (sodium cromoglicate), or leukotriene receptor antagonists.

Meeting one or two of those is not enough for a formal diagnosis under the consensus criteria, and many UK immunologists are strict about this.

Severity caveat. The Valent consensus was written around severe, episodic, anaphylaxis-level mast cell activation, not background or low-grade symptoms. The looser "consensus-2" (Afrin) criteria used in some patient communities are not the standard NHS immunology services apply. If your symptoms don't reach that threshold, NHS immunology may still investigate and rule out clonal mast cell disease, but a formal MCAS label is unlikely. That is the honest picture, not an argument against pursuing it.

The NHS route to a diagnosis

There is no single national NHS pathway for MCAS, but the practical route looks like this:

• GP appointment, document symptoms, triggers, organ systems involved, and timing.
• Baseline blood work at the GP: serum tryptase, total IgE, full blood count, vitamin D, basic metabolic panel.
• Referral to NHS adult immunology or allergy, where a service will accept one (see below).
• Specialist assessment, repeat tryptase, KIT D816V genetic test to rule out clonal mast cell disease, and a structured trial of treatment.

Referral, where a service will accept one, goes to adult immunology or allergy. There is no nationally commissioned NHS mast cell service and no published list of MCAS centres. Individual departments set their own referral criteria and several publish an explicit refusal. Manchester University NHS Foundation Trust states it does not see patients with suspected mast cell activation syndrome. The Northern Care Alliance allergy service at Salford lists mast cell activation syndrome among the conditions it does not offer a service for. UCLH accepts referrals where there is recurrent anaphylaxis. Read your own local service's published referral criteria before you ask, because whether you can be seen depends on those criteria and not on how unwell you are.

Waiting times for NHS immunology vary significantly by region, and some areas have very long waits. NHS England's 18-week referral-to-treatment standard is the published target, but in practice many specialist immunology services run well beyond that. NHS Right to Choose may let you choose a different NHS-contracted immunology or allergy provider with a shorter list, check the provider's current published waiting time before referral.

Individual NHS services publish their own referral inclusion and exclusion criteria. Leeds Teaching Hospitals Allergy & Clinical Immunology publishes a public referral page that shows the kind of criteria NHS services set. Before you click it, know what it says. Leeds accepts referrals where the picture is synonymous with idiopathic anaphylaxis, or where there are acute episodes of profuse urticaria or angioedema alongside acute gastrointestinal symptoms. It states that it does not accept referrals for what it calls unsubstantiated MCAS, and it names postural orthostatic tachycardia syndrome, hypermobility-type Ehlers-Danlos syndrome, chronic fatigue, fibromyalgia and brain fog as complaints it treats as independent of mast cell activation.

Some of those are symptoms listed on this page. That is deliberate on our part and uncomfortable on purpose: they are commonly reported by people with mast cell symptoms, and at the same time they are the grounds Leeds gives for declining a referral. Knowing that before you write to your GP is better than finding it out afterwards.

The tests to ask for

• Baseline serum tryptase, taken when you are well.
• Acute serum tryptase, taken within 1 to 4 hours of a flare (this is the key test, most diagnoses fail because no-one ever captures it).
• 24-hour urinary N-methylhistamine and 11β-prostaglandin F2α at specialist centres.
• KIT D816V genetic test on peripheral blood, to look for clonal mast cell disease.
• Specific IgE to suspected triggers, ruling out classical IgE-mediated allergy.

The single most important practical step is having a plan for the acute tryptase. Ask your GP for a phlebotomy form already filled out and held at the practice, so that when a flare happens you can walk in and have blood taken within the 1 to 4 hour window.

Private routes

If NHS waits are intolerable, a private consultation with an NHS-trained immunologist is the fastest route. Fees vary by clinic, expect a few hundred pounds for the initial appointment plus separate laboratory costs for tryptase and related panels. Always confirm the current fee with the clinic before booking. We do not hold a verified list of private mast cell clinics, so check the individual clinician's GMC registration and their published scope before you pay. A private diagnosis is recognised by the NHS as long as the consultant is GMC-registered and willing to write back to your GP.

What to ask your GP for, in writing

A short written request is much harder to deflect than a verbal one in a 10-minute appointment. At minimum, ask the GP for:

• Baseline serum tryptase, total IgE, FBC and vitamin D.
• A standing phlebotomy form for acute tryptase during a flare.
• Referral to NHS adult immunology or allergy, citing the international consensus criteria for MCAS.
• If a referral is being made and you want it to go to a particular NHS immunology or allergy service, ask for that service by name. In England the right to choose applies at the point of referral, but there is no NHS mast cell service to ask for, and the service you name will still apply its own published referral criteria.
• A trial of H1 and H2 antihistamines (for example fexofenadine plus famotidine, at a dose your GP decides) while waiting, as both diagnostic and therapeutic.

If your GP refuses to investigate at all, your situation is now about being heard, not about MCAS specifically. See our guide on what to do when your GP won't listen. A written letter sets out your symptoms, the relevant NHS guidance on suspected allergic and immunological disease, the GMC duty to refer when clinically appropriate, and a numbered set of requests, added to your medical record with a 28-day request for a review appointment.

After diagnosis

A formal MCAS diagnosis usually unlocks: a written management plan, prescription antihistamines and mast cell stabilisers, an EpiPen for anaphylaxis risk, trigger-avoidance advice, and access to disability protections under the Equality Act 2010 where the impact qualifies. Keep a copy of your specialist's diagnostic letter, it's the document everyone (insurer, employer, university, A&E) will ask for.

A note on our own benefits statistics. Elsewhere on this site we publish per-condition PIP award figures drawn from DWP data. Mast cell activation syndrome and mastocytosis are not separately recorded in those DWP condition categories, so there is no mast cell figure in that table and nothing there that tells you anything about a mast cell claim. We are saying so here rather than sending you to look.

Frequently asked questions